Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01358552 · ClinicalTrials.gov registry record
Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)
A clinical trial, sponsored by Pamlab.
- Terminated
- Registry status
- 53
- Enrollment target
NCT01358552: Clinical Trial study, sponsored by Pamlab.
NCT01358552 is a clinical trial that was terminated before completion, run by Pamlab. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01358552 was terminated before completion, sponsored by Pamlab.
- TERMINATED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This is an observational study in which patients who have been prescribed Néevo®/NéevoDHA® are invited to participate in surveys about their pregnancy and experiences with Néevo®/NéevoDHA®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for Néevo®/NéevoDHA®, provide patients with personalized education and support during their pregnancies, and contribute to the overall understanding of the needs and concerns of women facing intermediate- to high-risk pregnancies.
Primary Outcome
To collect data from patient surveys on the patient utilization and effectiveness of Néevo®/NéevoDHA® in a "real world" setting.
Interventions
- OTHER Néevo®/ NéevoDHA®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-03 |
Why NCT01358552 stopped before completion
NCT01358552 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Néevo®/ NéevoDHA® is the first listed.
NCT01358552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01358552 about?
NCT01358552 is a clinical study titled "Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)". This is an observational study in which patients who have been prescribed Néevo®/NéevoDHA® are invited to participate in surveys about their pregnancy and experiences with Néevo®/NéevoDHA®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who ar...
What is the current status of trial NCT01358552?
This trial is currently terminated. The enrollment target is 53 participants. The study started on 2011-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01358552?
The interventions under investigation include: Néevo®/ NéevoDHA® (OTHER).
Who is sponsoring clinical trial NCT01358552?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia